Literature DB >> 2356803

Counterpoint from a cluster buster.

R R Neutra1.   

Abstract

Mesh：

Year:  1990        PMID： 2356803     DOI： 10.1093/oxfordjournals.aje.a115621

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  26 in total

Review 1.  Cluster management and the role of concerned communities and the media.

Authors:  M Drijver; F Woudenberg
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

2.  The role of the assessment of spatial variation and clustering in environmental surveillance of birth defects.

Authors:  H Dolk
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

Review 3.  Methodological problems and the role of statistics in cluster response studies: a framework.

Authors:  P K Quataert; B Armstrong; A Berghold; F Bianchi; A Kelly; M Marchi; M Martuzzi; A Rosano
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

4.  A method for the follow-up of clusters of adverse reproductive outcomes.

Authors:  T Niyonsenga; P De Wals
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

5.  Answering cluster investigation requests: the value of simple simulations and statistical tools.

Authors:  Stéphanie Bellec; Denis Hémon; Jacqueline Clavel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Approaches to investigating clusters: by example, childhood leukaemia near Sellafield.

Authors:  M J Gardner
Journal:  Soz Praventivmed       Date:  1991

7.  Adequacy of state capacity to address noncommunicable disease clusters in the era of environmental public health tracking.

Authors:  Nadia Shalauta Juzych; Beth Resnick; Robin Streeter; Julie Herbstman; Joanna Zablotsky; Mary Fox; Thomas A Burke
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

8.  Regional variations in testicular cancer rates in Ireland: clusters and communities.

Authors:  U B Fallon; M T O'Mahony
Journal:  Ir J Med Sci       Date:  2011-02-02       Impact factor: 1.568

Review 9.  Cluster analysis and disease mapping--why, when, and how? A step by step guide.

Authors:  S F Olsen; M Martuzzi; P Elliott
Journal:  BMJ       Date:  1996-10-05

10.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Authors:  Steven Black; Juhani Eskola; Claire-Anne Siegrist; Neal Halsey; Noni MacDonald; Barbara Law; Elizabeth Miller; Nick Andrews; Julia Stowe; Daniel Salmon; Kirsten Vannice; Hector S Izurieta; Aysha Akhtar; Mike Gold; Gabriel Oselka; Patrick Zuber; Dina Pfeifer; Claudia Vellozzi
Journal:  Lancet       Date:  2009-10-31       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.